This site is intended for Healthcare Professionals only.

MHRA identifies two UK wholesalers selling Ozempic


Share post:

There is no evidence of the falsified pens being dispensed to UK patients’

The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that Ozempic has been found at two UK wholesalers on 18 October.

The pre-filled falsely labelled pens have been purchased from legitimate suppliers in Austria and Germany.

However, there has been no evidence that fake Ozempic has been supplied to UK patients.

The pre-filled falsely labelled pens have been purchased from legitimate suppliers in Austria and Germany. Credit: iStock

Dr Alison Cave, MHRA Chief Safety Officer spoke about closely with regulatory partners to ensure patients’ safety.

He said: “Buying semaglutide from illegally trading online suppliers significantly increases the risk of getting a product either falsified or not licensed for use in the UK.

“Products purchased in this way will not meet our strict quality and safety standards, and taking such medicines may put your health at risk,” he added.

“Anyone who suspects that they’ve had an adverse reaction to semaglutide or any other medicinal product, are worried about its safety or effectiveness, or suspect it is not a genuine product, should report it to our Yellow Card Scheme.”

The scheme allows the MHRA to oversee safety concerns, including reports of potential side effects or adverse events related to healthcare products.

Despite the falsified pens mimicking genuine German packaging, significant disparities exist when compared to authentic pens.

The Federal Institute for Drugs and Medical Devices (BfArM), Germany’s medicines agency, has released images showcasing the distinctions between real and counterfeit products.

A spokesperson from BfArM mentioned that they are currently analyzing the contents of the counterfeit pens, and there is uncertainty regarding the authenticity of the packages in which these pens were discovered.


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Another wake-up call! Nuffield Trust report warns patients face ‘new normal’ of medicine shortages

Community Pharmacy England has already warned that medicine shortages and market instability are “at the worst that pharmacies...

NHS supply chain appoints Richard Evans as commercial executive director

Experienced leader to drive transformation in healthcare supply chain through new NHS  appointment NHS Supply Chain today announced the...

UK launches Critical Imports Council to secure supplies of medicines, smartphone chips

The Council aims to address the supply challenges businesses face and develop real-life solutions The UK government has...

Health secretary accuses NHS gender care influenced by ‘cultural values’

Wes Streeting challenges plans for improving mental health assessments amidst growing scrutiny over NHS gender care  In a...